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Summary Individuals with Down syndrome often develop extensive gingivitis, and exhibit rapid
and generalized periodontal breakdown in early adulthood. Earlier studies reported a significant
prevalence of periodontal disease in patients with Down syndrome younger than 30 years old,
whereas recent studies have indicated that periodontal disease associated with the syndrome is
less severe than formerly thought, likely due to improved dental care at home and the dental
office. Although the etiology of the condition is not yet fully elucidated, a number of studies have
shown that Down syndrome related periodontitis is caused by such factors as immunological
deficiency, poor oral hygiene, fragile periodontal tissue, early senescence, salivary deficiency,
and poor masticatory function. In addition, those individuals experience very early colonization
by various periodontal pathogens, and exhibit an exaggerated innate immune response to
produce inflammatory mediators such as prostaglandin E2 and matrix metalloproteinases. Recent
studies regarding Down syndrome cell adhesion molecule (Dscam) provide further evidence for
increased susceptibility to bacterial and viral diseases in Down syndrome. In this review, an
overview of contemporary findings on the etiology of periodontal disease associated with Down
syndrome is presented.
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Down syndrome (Down’s Syndrome in British English and the
WHO International Classification of Diseases) is a genetic
disorder caused by the presence of all or part of an extra
21st chromosome [1]. It is named after John Langdon Down,
the English physician who initially characterized the appear-
ance and behavior of these patients in 1866, and one of the
most common causes of mental retardation in children. The
disorder was later identified as a chromosome 21 trisomy in
1959. The incidence of Down syndrome is estimated at 1 in
600—1000 live births, though those statistics are influenced
by several factors, in particular, the age of the mother [2,3].
The condition is characterized by a combination of general-
ized growth and mental deficiencies, and is associated with
several other pathological conditions, including congenital
cardiac defects and Alzheimer’s disease. In addition, hema-
tologic malignancies and autoimmune diseases such as
hypothyroidism, and type I diabetes mellitus, occur with
increased frequency in Down syndrome [3].
Nine major dental characteristics in Down syndrome chil-
dren have been reported, including macroglossia (enlarged
tongue), fissured tongue, underdeveloped maxilla, tongue
thrusting, congenitally missing teeth, malocclusion, high
arch palate, salivation, and microdontia [2,4]. One of the
most characteristic facial features of Down syndrome is a
relative underdevelopment of the middle third of the face.
There are also characteristic features in the craniofacial
anthropometric pattern profile in those afflicted, i.e., sub-Figure 1 Clinical outcome of early-onset periodontitis in Down syn
Down syndrome. Early-onset periodontitis generally occurs betwe
periodontitis appeared to be developed at early 20s, and deteriorat
typical symptoms of rapidly progressive periodontitis with significannormal scores for head length and circumference, as well as
external canthal distance.
In 1960, Cohen et al. first reported the marked prevalence
of periodontitis in young individuals with Down syndrome [5].
They examined the oral conditions of 100 young Down syn-
drome patients, and found that all had some form of period-
ontal disease, ranging from severe gingivitis in the youngest to
periodontitis with pocket formation and alveolar bone loss in
the older patients [5,6]. Subsequently, many investigations
revealed that children and adolescents with Down syndrome
often develop extensive gingivitis, and exhibit rapid and gen-
eralized periodontal breakdown in early adulthood [7]. The
precocious nature of the condition is thought to be due to such
factors as immunological deficiency, poor oral hygiene, fragile
periodontal tissue, early senescence, and poor masticatory
function [2,7], while it is also likely that short tooth roots lead
to tooth mobility and subsequent loss. Furthermore, several
recent reports have proposed a number of novel etiological
factors, which are described below. However, the etiology of
the disorder has not been fully elucidated. In this review, we
present the latest information on etiologic factors of early-
onset periodontal disease in Down syndrome based on abun-
dant findings reported by experts in the field.
2. Prevalence of periodontitis in Down
syndrome
Individuals with Down syndrome have an increased preva-
lence of periodontal disease as compared with normal anddrome. Panoramic radiograph image of a 29-year-old male with
en the ages of 15 (early adolescence) and 25. In this case,
ed at an accelerating pace. Finally, periodontal status exhibited
t alveolar bone resorption.
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tion [7,8—11]. The disorder develops at an early age and
shows conditions similar to those of early-onset periodontitis,
including juvenile and prepubertal periodontitis (Fig. 1)
[8,9]. Early epidemiological cross-sectional studies revealed
that more than 90% of Down syndrome patients under the age
of 30 years had periodontal diseases [6,8]. Furthermore, the
incidence of alveolar bone loss was found to be twice that of
mentally handicapped patients without Down syndrome,
with the prevalence of bone loss of 5 mm or more shown
in about 70% of the Down syndrome patients, who had a mean
age of 24 years [10]. Also, advanced bone loss (crest of the
interproximal bone located within the apical 1/3 of the root)
was noted in 65% of Down syndrome subjects with a mean age
of 35 years in another study [11]. Signs of alveolar bone loss,
mainly localized in the mandibular anterior region, have also
been reported in Down syndrome subjects as early as 11 years
of age [12]. A recent investigation showed that age was
significantly and positively correlated with probing depth
and alveolar bone loss in Down syndrome subjects
(mean  S.D.: 20.8  5.6 years) [13], and another report
confirmed a significant correlation between age and preva-
lence of bone loss in Down syndrome subjects with a mean
age of 17.7  7.1 years [14]. These findings suggest an age-
dependent prevalence for periodontal disease in young
adults with Down syndrome.
It is likely that someprogression of periodontal diseasewith
age is unavoidable in individuals with Down syndrome, how-
ever, all are not equally susceptible. Longitudinal studies of
these patients have shown that the disease progresses rapidly,
though the rate of progression varies among individuals [15—
18]. Systemic impairment of the host defense mechanism has
been proposed to contribute to the etiology of such rapidly
progressive disease in Down syndrome [19], while the subgin-
gival microbial profile was also noted as a cause.
It is noteworthy that more recent studies [13,14,20,21]
have found that the severity of periodontal disease in indi-
viduals with Down syndrome is now milder as compared with
that described in older studies [2,22—24]. This fact is likely
attributable to better dental care for these individuals, both
at home and the dental office, as compared with the past.
3. Factors related to early-onset periodontal
disease in Down syndrome
3.1. Local factors
3.1.1. Oral hygiene and calculus
Mental disability associated with Down syndrome is a major
factor in determining oral hygiene and likely has a large effect
on periodontal health, as well as oral bacterial ecology. Early
reports found that a majority of Down syndrome subjects
demonstrated poor oral hygiene as compared to healthy indi-
viduals [2,5—10]. Recently, it was also reported that themean
plaque score was 100% in Down syndrome subjects [25], in
agreement with other recent studies [20,21]. Though follow-
ing oral hygiene instructions, Down syndrome adults had a
reducedability tomaintainadequateplaquecontrol [25]. Even
in Down syndrome children, such a poor oral hygiene report-
edly gave rise to earlier, more rapid, and more extensive
gingival inflammation in deciduous dentition, as comparedto normal control children [7,26]. However, this situation
seems to be steadily improved by better dental care for these
individuals, both at home and the dental office, as compared
with the past. Indeed, some recent reports showed that better
oral hygiene existed in Down syndrome children [27], or there
was no significant difference as compared to healthy children
[28,29]. Furthermore, the effectiveness of a school-based,
supervised toothbrushing program was demonstrated in a
group of 112 Down syndrome individuals aged 11—22 years
old [30]. In consequence, the mean plaque score was signifi-
cantly decreased from 1.93 to 0.95, and mean gingival score
was reduced from 2.00 to 0.83 following supervised tooth-
brushing and dental health education sessions conducted
twice a week for 3 months. Though it might be a hard task
to educate adequate plaque control to Down syndrome indi-
viduals, an intensive education and care for oral hygiene have
been shown to be worthwhile.
Calculus deposits were formerly considered to be abun-
dant in Down syndrome children [5—7]. However, it was
recently reported that 90.6% (29 of 32) of Down syndrome
individuals aged 15—39 were calculus free, with a significant
difference as compared to the greater amount of calculus
accumulation in age/gender matched healthy controls [31].
Furthermore, other studies found no significant difference or
less prevalence of calculus accumulation in Down syndrome
subjects, as compared to healthy controls [32—34]. Despite
poor oral hygiene, calculus deposits are likely to be reduced
in Down syndrome individuals.
3.1.2. Oral function
Trisomy 21 induces poor neuromotor control, muscle weak-
ness, and dysmorphology [35]. Down syndrome children often
show an impairment in such oral functions as tongue protru-
sion, sucking, mastication, and swallowing due to a hypotonic
tongue and perioral muscles [36,37], and a large majority
(82.9%) reportedly held their lips apart in a habitual manner
[38]. Such impaired functions prevent the optimum tooth
intercuspation needed to stabilize the mandible and hyoid
bone during mastication and swallowing, thus feeding is par-
ticularly affected in infants and children with Down syndrome
[37,39], as well as in adults [40]. Abnormal chewing cycles and
lowered chewing efficiency were also suggested to lead to a
reduction in occlusal contact area [39]. In addition, mature
swallowing and chewing skills are impaired in Down syndrome
children [41,42]. A recent study also demonstrated that Down
syndrome adults also have a variety of feeding problems, such
as marked irregularities in masticatory time and cycle, and
significantly lower frequency of chewing [40]. These impaired
oral functions trigger traumatic occlusion and oral dryness,
which cause periodontal destruction in Down syndrome.Habi-
tual bruxism is also a cause of tooth mobility that accelerates
periodontal destruction, however, no significant difference in
bruxism frequency was found in Down syndrome children, as
compared to normal children [43]. Furthermore, no statisti-
cally significant associations between bruxism and age, sex, or
intellectual disability level were revealed.
3.1.3. Abnormalities in teeth and gingival tissues
3.1.3.1. Tooth morphology. Down syndromewas shown to be
associated with irregular crown and root shapes. In these
individuals, tooth crowns are usually shorter and smaller than
normal [2], and root length is also significantly reduced [2,44].
Figure 2 Inhibition of migration of gingival fibroblasts by P. gingivalis in Down syndrome. The effects of P. gingivalis on cellular
motility of gingival fibroblasts from Down syndrome and normal control subjects were examined using an in vitro wounding assay
(reproduced from Ref. [47], with permission). Confluent fibroblast layers were scratched with a plastic tip and the cells were infected
with P. gingivalis, after which subsequent cellular motility to fill the wounded scratched areas was assayed at 37 8C for 12 h. Bars show
the scratch wound regions at 0 h. Without infection, fibroblasts from both groups migrated to and filled about 60—65% of the scratched
area, with no significant difference in closure efficiency. In contrast, P. gingivalis infection diminished wound closure, with Down
syndrome fibroblasts found to be affected to a significantly greater degree than the control cells. These results suggest that gingival
fibroblasts in Down syndrome individuals are more susceptible to the inhibitory effects of P. gingivalis on cellular motility. Rates (%) of
wound closure for the scratched regions are shown under the images. *P < 0.05.
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gested to be a cause of periodontitis in Down syndrome [8].
3.1.3.2. Histological abnormalities in gingival tissue. His-
tological examinations revealed profound gingival inflamma-
tion in Down syndrome patients concomitant with
hyperinnervation of the gingival sensory component [45].
This hyperinnervation was considered to be due to a sprout-
ing of afferent nerves induced by inflammatory reaction and
also suggested to contribute to gingival inflammation in thesepatients. Alternatively, chemical transmitters released from
these nerves might be responsible for the inflammatory
reaction. In addition, capillary fragility of gingival tissues
was suggested to be related to the initiation and progression
of Down syndrome periodontitis [46].
3.1.3.3. Impaired migration of gingival fibroblasts. Cellu-
lar motility of gingival fibroblasts is a critical function for
wound healing and regeneration of periodontal tissues that
are destroyed in an inflammatory process [47]. Cellular
Figure 3 Adhesion to and invasion of fibroblasts by P. gingivalis. Gingival fibroblasts from Down syndrome and normal healthy
subjects were infected with various numbers of P. gingivalis (reproduced from Ref. [47], with permission). The adhesion and invasion
efficiencies of P. gingivalis were each significantly greater with the cells from the Down syndrome subjects. These results suggest that
Down syndrome fibroblasts allow the pathogen to invade more readily, thus preventing cellular motility due to the degradation of
cellular focal adhesion. Such characteristics likely have an effect on wound healing and regeneration of periodontal tissues in Down
syndrome individuals. Values for the efficiencies of bacterial adherence and invasion are shown as ratios (%). *P < 0.05.
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Down syndrome was significantly impaired by a periodontal
pathogen, Porphyromonas gingivalis, as compared to normal
gingival fibroblasts (Fig. 2), because the former were readily
invaded by P. gingivalis (Fig. 3) and intracellular pathogens
further impaired cellular focal adhesion, which is essential
for the migration of fibroblasts [48]. Thus, it is suggested that
P. gingivalis readily invades gingival tissue and subsequently
impairs cellular motility, resulting in prevention of wound
healing and regeneration of periodontal tissues, which are
characteristics likely involved in the etiology of periodontitis
in Down syndrome.
3.1.4. Salivary factors
Human saliva plays an important role in oral health, espe-
cially in protecting against noxious compounds produced by
microorganisms. Several salivary factors including salivary
flow rate, pH buffering capacity, calcium/phosphate concen-
tration, and secretory IgA (sIgA) have been shown to reduce
caries risk [48], though there is no agreement as to the actual
roles of these salivary factors in the pathogenesis of period-
ontal disease.
3.1.4.1. Salivary flow. With regard to salivary factors, no
significant differences were observed in the concentrations
of sialic acid, calcium, phosphorus, and magnesium between
20 Down syndrome and 18 control children aged 1—5 years old
[49]. In contrast, protein and sodium concentrations were
higher in the Down syndrome group, whereas flow rate, pH
level, amylase and peroxidase activities, and potassium
concentration were lower. Other studies also indicated a
lower flow rate in Down syndrome group aged 6—10 years
[50,51]. Although salivary flow in Down syndrome children
seems to be lower than in healthy individuals, it is noted thatsalivary pH, buffering capacity, and flow rate were quite
similar between 73 institutionalized Down syndrome children
and 70 normal children aged 7—12 years [29]. In adults,
salivary secretion is known to be decreased in an age-depen-
dentmanner in healthy subjects, and amore drastic decrease
was found in Down syndrome older subjects [48]. Another
study also showed that resting whole saliva flow rate in 70
Down syndrome adults was 0.05 ml/min (range, 0—0.41 ml/
min), compared to 0.55 ml/min (range, 0.05—1.64 ml/min)
in healthy control adults, indicating a 90% reduction, with a
significant reduction in stimulated parotid saliva secretion
also found [52]. Many other reports support an age-depen-
dent deficiency of salivary secretion in Down syndrome indi-
viduals [51,53—56].
3.1.4.2. sIgA. There is no consensus concerning the role of
the secretory immune system in the development of period-
ontal disease. However, bacterial colonization was shown to
be inhibited by salivary sIgA [57], and adults with low levels of
sIgA as well as the specific sIgA antibodies had an increased
risk of periodontitis and tooth loss [58,59]. In Down syndrome
children, significantly higher levels of salivary sIgA and a
marked lower prevalence of tooth caries were reported
[29,60]. Salivary sIgA seems to function to prevent tooth
decay. In contrast, older Down syndrome patients showed an
extreme reduction (>92%) in specific salivary sIgA against P.
gingivalis, Aggregatibacter (formerly Actinobacillus) actino-
mycetemcomitans, and Streptococcus mutans as compared
to age-matched controls [52]. Furthermore, an increased
vulnerability to recurrent upper respiratory infections was
attributed to this reduction in salivary sIgA secretion [56].
Such a severe salivary immunodeficiency related to age was
suggested to intensify the risk of periodontal destruction in
Down syndrome adults.
Early-onset periodontitis in Down syndrome 1233.1.4.3. Antimicrobial peptides. Antimicrobial peptides are
considered to play a major role in the first line of oral defense
[61]. These molecules have a direct bactericidal activity and
indirectly stimulate the immune system through chemotactic
activity as well as induction of cytokines. A deficiency in
salivary antimicrobial peptides has not been reported in
Down syndrome subjects, while salivary LL-37, a cationic
antimicrobial peptide, was found to be normally secreted in
those subjects [62]. However, salivary LL-37 at a normal
secretory level may be insufficient to prevent periodontitis
when accompanied with deficiencies in the oral mucosal
acquired immunity (IgA) and systemic immunity encountered
in Down syndrome patients.
3.1.5. Subgingival microbial profile
Earlier studies suggested that A. actinomycetemcomitans
was a causative agent for periodontal disease in Down syn-
drome [2,7,32]. However, previously, periodontal pathogens
were detected by culture techniques that were not generally
sensitive and required special skills, especially for the iso-
lation of anaerobic bacteria such as P. gingivalis. Following
the introduction of a polymerase chain reaction (PCR)
method to detect bacterial DNA in 1996 [63], subgingival
microbial profiles have become detectable with high speci-
ficity and sensitivity. Recent studies [20,64—67] have shown
that Down syndrome-specific periodontal pathogens do not
exist, but rather those found in those patients are similar to
pathogens related to ordinary periodontal diseases. Never-
theless, P. gingivalis, Treponema denticola, and Tannerella
forsythensis were found to be significantly prevalent in Down
syndrome children as compared to age-matched controls
[64], suggesting that periodontal pathogens colonize in the
very early childhood of Down syndrome individuals, with
early maturation of noxious microflora. A significantly
greater prevalence of P. gingivalis, A. actinomycetemcomi-
tans, and T. forsythensiswas also shown in 70 Down syndrome
subjects aged 8—28 years old, as compared with age-
matched healthy individuals and patients with cerebral palsy
[21]. These results suggest that virulent periodontal patho-
gens can colonize in early ages and subsequently survive in
the oral cavities of Down syndrome individuals.
In particular, P. gingivalis was reported to occur more
frequently with aging in Down syndrome individuals [21]. P.
gingivalis has been classified into six genotypes (types I—V
and Ib) based on the diversity of the fimA genes encoding its
fimbria subunits [68]. Accumulated evidence suggests that P.
gingivalis strains with type II fimbriae are the most period-
ontopathic clones in normal subjects. Interestingly P. gingi-
valis clones with types II or Ib fimbriae were also found to be
significantly related to initiation and progression of period-
ontitis in Down syndrome [20,66]. Further, periodontal her-
pesvirus—bacteria coinfection was suggested to play an
important role in the pathogenesis of periodontal destruction
in these individuals [67]. Herpesviruses may reduce period-
ontal defense and promote growth of subgingival bacteria
capable of causing periodontal breakdown.
3.2. Systemic factors
3.2.1. Systemic immunodeficiency
The initiation and progression of periodontal disease is lar-
gely dependent upon the host immune response, such ashumoral and cellular immunity [69]. It is well known that
Down syndrome individuals suffer from multiple impairments
in their systemic immune system, rendering them susceptible
to hematologic malignancies, autoimmune diseases, and
infectious diseases including periodontal disease [1,2,69].
Surprisingly, the etiologies of the proposed abnormal humoral
and cell-mediated immunological functions in Down syn-
drome have not been well clarified, with inconsistent results
reported [70]. However, apparent defects have been demon-
strated in B, T, and natural killer cell functions, as well as in
cytokine production, phagocytic and chemotactic responses,
and immunoglobulin function [71,72].
3.2.1.1. Phagocytic and chemotactic responses. Impaired
chemotaxis of neutrophils and monocytes, and reduced num-
bers and immature forms of Tcells has been well documented
in Down syndrome individuals. The initial finding of a neu-
trophil anomaly in Down syndrome showed less segmented
nuclei with normal numbers of neutrophils and leukocytes,
indicating the preponderance of younger cell forms [69]. This
phenomenon was considered to be due to a tendency for the
shortening of the half-life of circulating neutrophils in Down
syndrome. In addition, a significant reduction in neutrophil
chemotaxis was reported in Down syndrome children [73,74],
with defective chemotaxis also found to be significantly
correlated with the progression of periodontitis including
bone loss in Down syndrome patients [14]. The phagocytic
ability of Down syndrome neutrophils has also been shown to
be diminished, with significantly inefficient in vitro phago-
cytosis of Candida albicans reported [75]. Furthermore,
intracellular killing capacity was shown to be decreased
for a number of organisms, including Streptococus aureus,
Escherichia coli, and Candida albicans [75,76]. In addition,
peripheral T cells (lymphocytes) in Down syndrome subjects
were reported to be diminished both quantitatively and
qualitatively in regard to their ability to recognize and
respond to specific antigens [15].
3.2.1.2. Altered oxidative metabolism related to gene on
chromosome 21. Earlier studies suggested a great variation
in the oxidative metabolic potential of immune cells in Down
syndrome individuals, and a more recent and notable obser-
vation provides a new clue to the relationship between Down
syndrome and the immune system. The gene expression
profile analysis in T-lymphocytes from two patients with
Down syndrome showed over-expression of the superoxide
dismutase (SOD) gene which is located on trisomic chromo-
some 21q.16 [77]. SOD is a key enzyme in the metabolism of
oxygen-derived superoxide (O2
) to hydrogen peroxide
(H2O2) and SOD activity is increased in various tissues in
Down syndrome [78—80]. Although the relationship of SOD
with the immunopathology of Down syndrome is not well
elucidated, increased H2O2 produced by abundant SOD may
react with transition metals like iron to form the hydroxyl
radical, which can initiate lipid peroxidation resulting in
damage to cell membranes [81]. Thus, an increase in SOD
activity theoretically reduces immunity in Down syndrome
individuals. First, such an increase would also increase H2O2,
which may damage immune cells and impair cellular signal
transduction events involved in phagocytosis. Second, it
would decrease the concentration of O2
, resulting in a
decrease in the bactericidal activity of phagocytes. These
Figure 4 Exaggerated expression of inflammatory mediators
by Down syndrome gingival fibroblasts after infection with P.
gingivalis. Cultured gingival fibroblasts from Down syndrome
(Down) and normal control (Control) subjects were infected with
P. gingivalis. IL-6 and COX-2 were significantly induced in the
Down specimens as compared to the control specimens (Ref.
[92]). These results suggest that Down syndrome gingival fibro-
blasts have an exaggerated inflammatory response upon infec-
tion of P. gingivalis, resulting in severe periodontal destruction.
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trophils from individuals with Down syndrome were shown to
produce less O2
 than those without Down syndrome. Also, a
two-fold overproduction of SOD in intraperitoneal macro-
phages from transgenic mice resulted in inhibition of extra-
cellular release of O2
, increased intracellular production of
H2O2, and reduced microbicidal and fungicidal activities
[82,83].
3.2.1.3. Dscam (Down syndrome cell adhesion molecule)
gene on chromosome 21. Another recent finding is Dscam
(Down syndrome cell adhesion molecule), which was isolated
from chromosome 21q22.2-22.3, and shown to be a novel
member of the immunoglobulin superfamily and in a unique
class of neural cell adhesion molecules that are relevant to
neural wiring [84]. Watson et al. [85] detected protein iso-
forms of Dscam in Drosophila hemocytes and found that loss
of Dscam impaired the phagocytic uptake of bacteria, pos-
sibly due to reduced bacterial binding such as a diminished
expression of surface glycoproteins needed for adhesion to
bacteria. The Dscam gene contains 116 coding regions encod-
ing about 20,000 different proteins. The potential ability of
Dscam to generate a large protein isoform-repertoire and
recognize diverse ligands may be a major link between the
nervous and immune systems. It has also been hypothesized
that there is increased deletion of thymocytes in the Down
syndrome thymus and a diminished proportion of mature T
cells.
3.2.1.4. Early senescence of immune system in Down
syndrome. An interesting question has arisen regarding
whether immunedysfunction inDown syndrome is a congenital
immune deficiency or early senescence of the immune system
[86], because amajority of individualswith Down syndrome do
not show severe features of immunological disease. Many of
the above-mentioned immunological alterations may be age-
related changes and can be included in the spectrum of multi-
ple signs of early senescence characteristic of the syndrome.
Although recent studies regarding SOD and Dscam provide
further support for the increased susceptibility to bacterial
and viral diseases inDown syndrome, further investigationsare
necessary to fully address the above question.
3.2.2. Inflammatory mediators and proteolytic
enzymes
Periodontal pathogens such as P. gingivalis stimulate period-
ontal cells to produce inflammatory mediators such as pros-
taglandin E2 (PGE2), matrix metalloproteinases (MMPs), and
proinflammatory cytokines including interleukin (IL)-1, IL-6,
and IL-8 [87]. These mediators further activate host cells to
mount excessive host inflammatory responses. Down syn-
drome individuals are likely to exhibit exaggerated inflam-
matory responses upon periodontal infection [87—91]. A.
actinomycetemcomitans lipopolysaccharide significantly
enhanced PGE2 production through the induction of mRNA
expression of COX-2 (PGE2-producing enzyme) by gingival
fibroblasts from Down syndrome subjects [88]. We also found
that P. gingivalis infection significantly induced mRNA
expressions of COX-2 as well as IL-6 by gingival fibroblasts
in these individuals (Fig. 4) [92]. Excessive expressions of
MMPs are responsible for periodontal breakdown [93], while
collagenase activities comprised mainly of MMP-8, MMP-9,and MMP-2 in saliva and gingival crevicular fluid were
reported to be higher in Down syndrome children as com-
pared to the age-matched healthy subjects [88]. Also, the
expressions of membrane-type MMP-1 and MMP-2 by gingival
fibroblasts of Down syndrome individuals were found to be
augmented, as compared with those of healthy controls [89].
Furthermore, the inhibitory capacity of TIMP-2 against acti-
vated MMP-2 was repressed in Down syndrome patients [90].
These features are likely involved in the periodontal destruc-
tion seen in individuals afflicted with the syndrome.
4. Conclusion
Collectively, individuals with Down syndrome likely respond
to common bacterial challenges in an exaggerated manner,
due to multiple factors, and develop more severe forms of
periodontal disease. There is a higher incidence of oral health
problems among individuals with Down syndrome, particu-
larly after 10 years of age [13,14,20], indicating the need for
better teaching of tooth brushing and more regular visits to
the dentist. Conventional standard procedures of oral
hygiene instruction, scaling, and root planing, as well as
surgical therapy lead to significant improvements in Down
syndrome patients [25,91]. In addition, some products such
as the Castillo-Morales palatal plate have been developed to
improve impairments in such oral functions as tongue pro-
trusion, sucking, mastication, and swallowing [94,95].
Although there is little doubt that a patient with Down
Early-onset periodontitis in Down syndrome 125syndrome is at increased risk for periodontitis, periodic
preventive care including rigorous bacterial plaque control
is necessary for suppressing the progression of periodontal
disease in these individuals. Down syndrome is the second
most frequent congenital disorder encountered in the oral—
dental field, next to cleft palate/lip [7], thus further inves-
tigations are important to elucidate the etiologic factors
involved in periodontal disease related to the condition.
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